Suppr超能文献

昆士兰肾移植人群中患非黑色素瘤皮肤癌的风险

Non-melanoma skin cancer risk in the Queensland renal transplant population.

作者信息

Ramsay H M, Fryer A A, Hawley C M, Smith A G, Harden P N

机构信息

Department of Dermatology, North Staffordshire Hospital, Stoke-on-Trent, Staffordshire ST4 7LN, U.K.

出版信息

Br J Dermatol. 2002 Nov;147(5):950-6. doi: 10.1046/j.1365-2133.2002.04976.x.

Abstract

BACKGROUND

Non-melanoma skin cancer (NMSC) is an important complication of solid organ transplantation, especially in areas of high ultraviolet light exposure. Registry data may underestimate the scale of the problem.

OBJECTIVES

A single-observer study of a Queensland renal transplant population was conducted between July 1999 and April 2000 utilizing both cross-sectional and retrospective data. The aims were to determine accurately the risk of NMSC following renal transplantation and compare this with currently available registry data.

PATIENTS AND METHODS

A structured interview and full skin examination was completed by 398 renal transplant recipients. Case notes and histology reports were examined for details of previous skin tumours. Independently collected data on 341 subjects from the Australia and New Zealand Dialysis and Transplantation Registry (ANZDATA) were also examined.

RESULTS

One hundred and eighty-seven of 361 (51.8%) transplant recipients of Fitzpatrick skin types I-IV had developed 3979 histologically diagnosed NMSCs since first transplantation. The ratio of SCC/BCC was reversed from 1 : 3.7 before transplantation to 2 : 1 after transplantation. NMSC increased with duration of immunosuppression; 29.1%, 52.2%, 72.4% and 82.1% of those immunosuppressed for < 5, 5-10, 10-20 and > 20 years, respectively, had developed at least one tumour. The ANZDATA registry under-recorded the numbers of patients with NMSC by 28.4% and gave no indication of tumour numbers.

CONCLUSIONS

NMSC is a greater clinical problem in renal transplant recipients living in subtropical Queensland, Australia, than is shown by currently available registry data. This has implications for the development of prevention and surveillance strategies.

摘要

背景

非黑色素瘤皮肤癌(NMSC)是实体器官移植的一种重要并发症,尤其是在紫外线暴露量高的地区。登记数据可能低估了该问题的规模。

目的

1999年7月至2000年4月间,对昆士兰肾移植人群进行了一项单观察者研究,采用横断面和回顾性数据。目的是准确确定肾移植后发生NMSC的风险,并将其与目前可用的登记数据进行比较。

患者和方法

398名肾移植受者完成了结构化访谈和全面的皮肤检查。检查病历和组织学报告以获取既往皮肤肿瘤的详细信息。还检查了从澳大利亚和新西兰透析与移植登记处(ANZDATA)独立收集的341名受试者的数据。

结果

自首次移植以来,361名I-IV型菲茨帕特里克皮肤类型的移植受者中有187名(51.8%)发生了3979例经组织学诊断的NMSC。鳞状细胞癌/基底细胞癌的比例从移植前的1:3.7逆转至移植后的2:1。NMSC的发生率随免疫抑制时间的延长而增加;免疫抑制时间<5年、5-10年、10-20年和>20年的患者中,分别有29.1%、52.2%、72.4%和82.1%发生了至少一种肿瘤。ANZDATA登记处记录的NMSC患者数量少了28.4%,且未显示肿瘤数量。

结论

在澳大利亚昆士兰亚热带地区生活的肾移植受者中,NMSC是一个比目前可用登记数据所显示的更为严重的临床问题。这对预防和监测策略的制定具有重要意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验